1. Executive Summary

The key analytical takeaway is that Vishay’s print was not primarily about a small revenue beat or a one-cent EPS outcome. It was about whether Vishay has moved from cyclical stabilization into a real order/backlog-led upturn. The answer from the quarter and call was directionally yes: book-to-bill stepped to 1.20 from 0.97, backlog moved to $1.3B / 4.9 months from 4.4 months, and management soft-guided sequential revenue growth through 2026. The single most important change versus the prior-quarter framing is that the demand narrative moved from directionally positive and short-turn driven to orders at three-year highs across most technologies and channels with improving billable backlog visibility.

The constructive read still depends on conversion. The setup weakens if 1Q revenue does not hold around the $815M midpoint, if book-to-bill falls back toward parity, if Newport fails to exit 1Q gross-profit neutral, or if the $153M quarterly SG&A run-rate absorbs the revenue recovery. Immediate post-print price action was negative because revenue and backlog strength did not translate cleanly into EPS, margin, or FCF revisions. Current market data show the stock has subsequently re-rated sharply, making incremental upside more dependent on estimate catch-up and operating leverage than on cycle recovery alone.

• Bookings and backlog were the highest-signal positives: total book-to-bill rose to 1.20, semis to 1.27, passives to 1.13, and backlog reached $1.3B / 4.9 months. That improves revenue visibility and supports the Vishay 3.0 capacity-readiness thesis, but it now needs to convert into gross margin and EPS.
• Revenue beat quality was better than the magnitude: revenue of $800.9M was above consensus of $793.7M and above the $790M guide midpoint, with industrial and AI-related Other driving the sequential growth. The beat itself was modest; the mix and order flow mattered more.
• Margin quality remained the gating issue: gross margin was 19.6%, in line with Street and slightly above the guide midpoint, but operating margin fell sequentially to 1.8% as SG&A stepped to $142M. 1Q SG&A guidance of $153M creates an operating leverage hurdle even as volumes recover.
• Newport is moving from drag to potential swing factor: Newport was about a 130 bp gross-margin headwind in 4Q, improving from 3Q, and management guided a 50 to 75 bp drag in 1Q with an exit-rate goal of gross-profit neutral and accretive thereafter. This is a critical bridge item for 2026 margin confidence.
• Estimate revisions are bifurcated: revenue is up, EPS is down. Bloomberg revision data in the supplied text show 1Q revenue consensus moved from about $801M pre-print to $820.5M, while 1Q EPS fell from $0.092 to $0.019 and FY26 EPS fell from $0.843 to $0.54. The market is paying for the cycle before EPS conversion is visible.
• FCF was optically strong but not clean: 4Q FCF was +$54.9M, but CFO included $62M from receivables securitization, and management expects negative FCF again in 2026 due to $400 to $440M of capex. Cash conversion is not yet a durable thesis support.
• The stock debate has shifted: at $25.92, VSH is well above the current $20 consensus target and trades with an RSI above 80. The bullish case now requires sell-side estimates and targets to catch up through backlog conversion, while the bear case is that EPS and FCF remain structurally below what the stock is discounting.

2. What Actually Mattered

3. Results Versus Expectations

4. Historical Quarterly Comparison

The quarter shows improving demand and backlog, but not yet durable operating leverage. Revenue rose sequentially, gross margin edged up, and bookings strengthened, but operating margin fell because SG&A rose faster than gross profit. Cash conversion looked better sequentially, but receivables securitization flattered CFO, and 2026 capex guidance keeps FCF quality mixed.

5. Guidance Bridge and Implications

The bridge is primarily demand-led on revenue and normalization-led on margin, with a meaningful offset from opex and capex. Management’s confidence came from book-to-bill, backlog, customer engagement, and growth in industrial power, AI-related power, auto content, aerospace and defense, and healthcare. J.P. Morgan’s post-print note adds an important outside check: existing billable backlog for Q2, Q3, and Q4 points to faster growth than in the prior three years. That meaningfully strengthens the revenue bridge beyond the headline 1Q midpoint.

The margin bridge is more fragile than the headline +30 bp gross-margin guide suggests. A large part of the improvement comes from Newport drag stepping down from about 130 bps to 50 to 75 bps, while metals inflation, tariff effects, and still-negative but less severe annual pricing resets remain offsets. In other words, early-2026 gross-margin improvement would still be more a normalization story than proof that Vishay has already reached clean operating leverage.

The EPS bridge is therefore less clean than the revenue bridge. SG&A steps to $153M from $142M, management is still investing in R&D and customer-facing activities, and FY26 capex will be $400 to $440M. That leaves the setup constructive for revenue revisions but less automatically constructive for EPS and FCF until volume, mix, and Newport improvement start to fall through to EBIT.

• Book-to-bill rolls over toward 1.0 before backlog converts into shipments.
• Newport does not exit 1Q gross-profit neutral, or automotive site audits and PCN approvals slip.
• Metals, tariffs, or FX offset the benefit of price increases and volume efficiency.
• SG&A exceeds the guided $153M quarterly level, or revenue growth fails to absorb it.
• FY26 capex requires more revolver usage than expected and pushes out FCF recovery.

6. Estimate Revision Implications

Revisions are likely to remain broad-based upward for revenue but narrow and mixed for EPS. The demand evidence is strong enough to support higher sales forecasts, but EPS revisions require confidence that Newport, pricing, mix, and volume efficiency can overcome SG&A and input-cost inflation. This is a constructive revenue setup but only a conditional EPS setup.

The revision path improves if 1Q revenue lands above midpoint with gross margin at or above 19.9%, Newport exits neutral, and management can hold SG&A around $153M per quarter. It stalls if revenue moves up but gross margin stays near 20% and FY26 FCF remains deeply negative. It reverses if backlog reflects temporary replenishment rather than end-demand conversion.

7. Transcript Intelligence

Management tone was notably more confident than the prior quarter. The prepared remarks emphasized capacity readiness, broad-based order growth, backlog development, AI-related power, industrial recovery, automotive share opportunities, and the idea that Vishay 3.0 is becoming visible in revenue generation. The tone was not purely promotional: management also acknowledged shortages and escalations, metals and input costs, Newport drag, elevated capex, and negative 2026 FCF.

Management’s demand framing was broader than a simple restock narrative. Smejkal said automotive, industrial power, aerospace-defense, AI computing, and healthcare represent about 95% of Vishay’s core business. He also said customers are responding to Vishay 3.0 with deeper technical engagements, greater collaboration, and a willingness to scale long term. That matters because it suggests the improved orders and backlog are being supported by both cyclical recovery and better competitive positioning.

Analysts focused on the right issues: whether end-market growth expectations improved versus 90 days ago, whether gross margin can expand despite metals and ASP pressure, whether automotive share gains are real or just crisis support, whether memory constraints can affect AI and server power demand, and whether capex and opex will normalize. Management answered directionally well but avoided quantifying some of the most investment-relevant items, especially the revenue contribution from automotive share gains, the full-year gross-margin cadence, and M&A specificity.

• Peter Peng, J.P. Morgan, pressed on industry growth versus 90 days ago. This mattered because the post-print bull case depends on whether VSH can outgrow a mid- to high-single-digit end market.
• Peter Peng, J.P. Morgan, also pressed on gross margin, metals, and annual price negotiations. This was the key EPS question, and management framed ASP declines as much less than historical with price increases underway.
• Ruplu Bhattacharya, Bank of America, tested whether the auto opportunity is structural or just short-term shortage support, and whether future capacity will be sufficient.
• Shadi Mitwalli, Needham, focused on memory pricing and supply constraints, which matters because AI/server demand can still be constrained by upstream components outside Vishay’s control.
• Management was less explicit on the quantified 1Q revenue benefit from auto share gains, the full-year gross-margin path, the cadence of negative FCF in 2026, and how much of the backlog is true end demand versus replenishment.

The key cross-quarter delta is that 3Q25 management language was still early-cycle, short-turn, and cautiously constructive, while 4Q25 language moved to order-led recovery, backlog visibility, and share-capture confidence. In 3Q, management described the setup as directionally positive, but still constrained by customers not planning ahead and relying on turns, expedites, and pull-ins. By 4Q, management was pointing to orders at a three-year high, backlog up to 4.9 months, and 2026 as the year Vishay 3.0 begins to convert into revenue growth.

The investment conclusion is not simply that management sounded more bullish. The real change is that the recovery is now supported by harder indicators: book-to-bill moved from 0.97 to 1.20, backlog moved from $1.2B / 4.4 months to $1.3B / 4.9 months, distribution inventory improved from 23 weeks to 22 weeks, and management guided sequential revenue growth into 1Q26 despite Lunar New Year pressure. The offset is that the improved demand language did not yet translate into clean EPS or FCF conversion, given higher SG&A, metals pressure, and a heavier FY26 capex plan.

J.P. Morgan’s post-print read adds the strongest external validation of the conversion story: the firm said existing billable backlog for Q2, Q3, and Q4 already points to faster growth than in the prior three years. That does not guarantee earnings conversion, but it does raise the burden of proof for the bear case that backlog is only short-term replenishment.

• Demand / Orders, Joel Smejkal: orders for the fourth quarter are at a three-year high across all main product technologies, except capacitors.
• Demand / Orders, Joel Smejkal: backlog at quarter end is $1.3 billion or 4.9 months.
• Industrial, Joel Smejkal: for Vishay, industrial is back.
• Pricing / Metals, Joel Smejkal: the resulting price decrease is much less than what was historical.
• Newport / Margin Bridge, David McConnell: we still expect to exit quarter one with Newport gross profit neutral and accretive thereafter.
• 2026 Outlook, Joel Smejkal: 2026 is our year to take off.

The automotive share-gain story also deserves tighter framing. Management’s claim is not just that December shortages created emergency shipments. It is that Vishay used available capacity to support OEMs and Tier 1s, opened new part-number and platform opportunities, and is now waiting on audits and PCN approvals for fuller conversion. That makes the opportunity more structural than a one-quarter shortage fill, but still clearly execution-gated.

Bottom line: the cross-quarter upgrade is real and broad-based. Orders, backlog, industrial, AI/server power, distribution health, EMS participation, Newport drag, and auto share-gain optionality all improved versus the prior quarter. The part that did not improve is earnings quality: operating margin fell sequentially, SG&A reset higher, FY26 capex moved up sharply, and free cash flow remains negative on a full-year basis. The bullish read depends on the 4Q order and backlog inflection converting into 2026 revenue and gross-margin expansion rather than being absorbed by metals, tariffs, SG&A, and capacity spend.

8. Segment and KPI Forensic Review

The best validation of the thesis is the combination of book-to-bill, backlog, lower distribution inventory, industrial growth, and AI-related Other growth. That is enough to support upward revenue revisions. The unresolved KPI is conversion: VSH still needs to show that higher volumes, Newport normalization, and price actions can drive gross margin and EPS higher despite the SG&A and capex step-up.

Confidence changes meaningfully if 1Q shows revenue above the $815M midpoint with gross margin at or above 19.9%, book-to-bill still comfortably above 1.0, and Newport exiting neutral. Conversely, a strong revenue quarter with no margin progression would reinforce the bear case that Vishay is buying growth with capacity and opex.

9. Quality of the Quarter

The quarter’s quality was clearly better on demand and backlog than on earnings conversion. Revenue, orders, and backlog all improved in ways that support higher revenue estimates, but operating leverage, cash-flow quality, and durability of the margin bridge remain only partially proven.

• Revenue Quality — HIGH. Revenue growth was modest q/q but supported by broad-based bookings, a 1.20 book-to-bill, higher backlog, and clear strength in industrial power and AI-related applications. The mix is better than the headline because growth was tied to identifiable end-market drivers rather than only channel restock. The risk is that some demand reflects inventory replenishment and extended lead times.
• Margin Quality — MIXED. Gross margin was in line and slightly improved sequentially, but operating margin declined because SG&A stepped up. Newport drag is improving, which is structurally positive, but metals, tariffs, ASP resets, and higher opex keep the margin recovery unproven. This was not yet a clean operating leverage quarter.
• EPS Quality — LOW / MIXED. EPS was positive but only $0.01 and below consensus. Low pre-tax income made the effective tax rate noisy, and SG&A was above guide. EPS quality will remain low until revenue growth translates into visible EBIT expansion.
• Cash Flow Quality — MIXED. 4Q FCF was positive at $54.9M, but CFO included $62M from receivables securitization. FY25 FCF remained negative, and management expects negative FCF again in 2026 due to capex. The quarter improved liquidity optics but did not prove durable cash conversion.
• Backlog / Pipeline Quality — HIGH. Backlog rose to $1.3B / 4.9 months, total book-to-bill was 1.20, and management said orders were at three-year highs across most technologies and channels. This is the highest-quality aspect of the print and the main reason revenue estimates moved up.
• One-Time Items / Accounting Distortion Risk — MIXED. There were no major 4Q adjusted EPS add-backs comparable to prior impairment or restructuring items, but the cash-flow statement was affected by receivables securitization and the effective tax rate is not meaningful at low profit levels. FY2025 SG&A also included an $11.3M benefit from favorable resolution of a contingency, so annualized opex comparisons need care.

The funding picture is tighter than the headline cash balance suggests. Cash and short-term investments rose to $515M, but U.S. revolver borrowings also increased to $219M and accessible revolver liquidity fell to $254M. With FY26 capex still guided to $400 to $440M and management expecting negative free cash flow again in 2026, the quarter improved liquidity optics more than it proved self-funded cash generation.

10. Options and Volatility Diagnostics

Positioning and technicals are now stretched but not complacent. The stock has strong momentum, high RSI, and a call-heavy options profile, but short interest is still elevated. That combination can support further squeeze if estimates move up, but it also increases downside sensitivity to any failure in 1Q conversion.

11. Stock Reaction Drivers

Primary Driver. The immediate negative stock reaction is best understood as a conversion concern. Revenue and backlog were good, but investors had to absorb lower gross-margin expectations, higher SG&A, elevated capex, and negative FY26 FCF. That explains why revenue estimates went up while EPS estimates went down.

Secondary Driver. The secondary driver was the quality of the demand inflection. Book-to-bill of 1.20 and backlog of 4.9 months gave bulls enough evidence to underwrite a revenue recovery. This is the reason the stock could later re-rate despite the initial post-print drawdown.

Tertiary Driver. Auto share gains and AI/server power exposure added option value. They are not yet large enough to be the primary driver, but they support the case that VSH can outperform underlying end-market growth.

Context. At the time of the JPM note, the stock had already moved significantly, and by the current datapack date it is +78.9% YTD, above the consensus target, and technically overbought. That means the bar has moved from show orders to show earnings and FCF.

What was not the primary driver. The primary driver was not the $7M revenue beat or the $0.01 EPS miss in isolation. Those were visible but low signal. The stock debate is now about whether the 2026 revenue recovery can produce a 2027 earnings and FCF profile that justifies the re-rating.

12. What Mattered Less Than It Appeared

• The one-cent EPS miss. It looked negative, but the real issue was the forward EPS bridge, not the penny itself.
• The 4Q revenue beat magnitude. The beat was modest; the more important signal was backlog and book-to-bill quality.
• The automotive q/q decline. Auto revenue was down due to holiday pull-rate seasonality in the Americas and Europe, while orders grew in each region.
• The aerospace and defense q/q decline. Management attributed weakness to government shutdown and project timing, while orders increased.
• Positive 4Q FCF. FCF was optically strong but flattered by $62M of receivables securitization and does not offset negative FY26 FCF guidance.
• The headline GAAP tax rate. The 82.3% effective tax rate is noisy because pre-tax income is very low.
• M&A commentary. Management kept M&A on the table, but there was no specific transaction, timing, or estimate impact.

13. Post-Print Analyst Activity

J.P. Morgan’s target-price change matters more for framework than for the absolute number. The firm raised its target to $20 from $14 while cutting CY26 EPS to $0.38 from $0.64 and explicitly based the new target on 21x CY27 EPS of $0.95, a discount to roughly 27x peer multiples because of Vishay’s lower margin profile. That means the more constructive post-print framing was not about near-term EPS cleanliness. It was about the market’s willingness to look through a messy 2026 and capitalize a 2027 normalization story.

Current consensus summary: the supplied datapack shows 2 Buy / 1 Hold / 1 Sell, with mean and median target price of $20.00. Versus the current price of $25.92, the consensus target implies about 23% downside. The supplied broker-level action table includes target prices from $15.36 to $28 among post-print actions, but the current consensus target field remains $20. In practice, the stock was already trading ahead of the published sell-side target framework at the supplied market-data date, which increases the importance of FY27-style normalization logic.

• Revenue revisions are most likely to keep moving up if 1Q bookings and backlog remain strong.
• Hold- and sell-rated analysts are most likely to focus on EPS conversion, capex, FCF, and whether the stock has outrun the target-price framework.
• Bullish notes should shift language from cyclical recovery to share gains and backlog conversion only if 1Q confirms the bridge.
• Channel checks should focus on distribution inventory weeks, POS, auto audits, AI/server power programs, and industrial smart-grid shipments.
• Model changes are most sensitive to gross margin, SG&A run-rate, and FY26 capex cadence.

14. Peer and Sector Read-Through

• Power-related demand is improving across AI/server, industrial power, smart grid, and automotive content. This is not a consumer-led recovery.
• Channel inventory normalization is a positive read-through: VSH distribution inventory fell to 22 weeks and POS increased 3%.
• Diode and MOSFET lead-time extension creates a near-term share and pricing opportunity, but can also pull orders forward.
• Metals and tariffs remain a sector-wide margin risk for standard components and passives.
• Capacity readiness is becoming a competitive differentiator, but it comes at a 2026 FCF cost.
• AI power exposure is real for VSH, but investors should not underwrite AI-like margins. This remains a components model with heavy operating-leverage requirements.

15. Investment Implications

Near-Term (1 to 5 trading days). Stock behavior is likely to remain volatile and technically driven. The current setup is momentum-positive but stretched: price is well above both the 50D and 200D averages, RSI is above 80, and consensus target price is below spot. Further near-term upside requires either estimate upgrades, target-price catch-up, or short-covering. Downside risk rises if investors refocus on FY26 EPS and FCF rather than revenue momentum.

Next Quarter. The next print is the key confirmation event. The stock needs 1Q revenue at or above the $815M midpoint, gross margin near or above 19.9%, book-to-bill still above parity, and Newport exiting gross-profit neutral. If revenue beats but SG&A and input costs absorb the upside, the market will likely treat the print as a revenue-only recovery with limited EPS quality.

Next 6 to 12 Months. The medium-term setup is constructive but valuation-sensitive. The stock was already trading above the $20 consensus and J.P. Morgan target at the supplied market-data date, which means investors are already capitalizing some 2027 normalization before Vishay has fully proven 2026 FCF. Upside requires VSH to prove that Vishay 3.0 can drive share gains and above-market revenue growth while Newport, pricing, and volume efficiency restore margin. Downside comes from a revenue recovery that fails to produce FCF due to $400 to $440M of capex and elevated opex. Re-rating depends on the market gaining confidence in FY27 EPS and FCF, not just FY26 revenue.

16. What to Watch Next

17. Appendix

Senior Executives on Call

• Joel Smejkal, President & Chief Executive Officer
• David McConnell, Executive Vice President & Chief Financial Officer
• Peter Henrici, Executive Vice President, Corporate Development

Sell-Side Analysts on Call

Notable Analyst Focus in This Call. Analysts were focused less on the reported quarter and more on 2026 conversion: whether higher orders and backlog can become revenue, whether pricing and Newport can restore gross margin, whether capex peaks as promised, and whether automotive and AI opportunities are material enough to change the medium-term earnings power.

Methodology note. This report preserves the more detailed expanded cross-quarter comparison supplied in the source text and does not duplicate the earlier shorter version. Source information is listed at the end of the report in the standard source block rather than as inline citations.